Publications by Dr Asima Mukhopadhyay - ePrints

Browsing publications by Dr Asima Mukhopadhyay.

Newcastle Authors	Title	Year
Dr Asima Mukhopadhyay	Retraction note: Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells (Cell Death & Disease, (2018), 9, 10, (934), 10.1038/s41419-018-0989-8)	2024
Dr Santu Saha Dr Stuart Rundle Dr Ioannis Kotsopoulos Dr Jake Begbie Rachel Howarth et al.	Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy	2022
Hannah Smith Dr Elaine Willmore Dr Asima Mukhopadhyay Dr Yvette Drew Professor Nicola Curtin et al.	Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling	2022
Dr Asima Mukhopadhyay	Economic evaluation of population-based BRCA1/BRCA2 mutation testing across multiple countries and health systems	2020
Dr Asima Mukhopadhyay Dr Yvette Drew Liz Matheson Dr Mo Salehan Lucy Gentles et al.	Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors	2019
Lucy Gentles Bojidar Goranov Elizabeth Matheson Dr Ashleigh Herriott Dr Angelika Kaufmann et al.	Exploring the frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types	2019
Dr Asima Mukhopadhyay	Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells	2018
Dr Ioannis Kotsopoulos Dr Asima Mukhopadhyay Professor John Lunec Professor Nicola Curtin Ali Kucukmetin et al.	IN VITRO SINGLE AGENT RUCAPARIB CYTOTOXICITY AND CISPLATIN CHEMO-POTENTIATION IN CERVICAL CANCER CELL LINES	2016
Dr Ganiy Abdulrahman Elizabeth Matheson Dr Yvette Drew Professor Nicola Curtin Dr Asima Mukhopadhyay et al.	Investigating PARP inhibitor sensitisation by hyperthermia and HSP90 inhibition	2016
Dr Rachel O'Donnell Dr Stuart Rundle Dr Ioannis Kotsopoulos Chun Ang Ali Kucukmetin et al.	Metastatic involvement of the lesser sac in advanced epithelial ovarian cancer	2016
Dr Asima Mukhopadhyay	Ovarian cysts and cancer in pregnancy	2016
Dr Ioannis Kotsopoulos Ali Kucukmetin Dr Asima Mukhopadhyay Professor John Lunec Professor Nicola Curtin et al.	Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis Mechanism and Potential Role for PARP Inhibitors	2016
Elizabeth Matheson Dr Mo Salehan Dr Asima Mukhopadhyay Professor Nicola Curtin Dr Yvette Drew et al.	Preclinical studies of the PARP inhibitor olaparib in combination with imatinib in BRCA stratified ovarian cancer	2016
Dr Rachel O'Donnell Dr Stuart Rundle Dr Ioannis Kotsopoulos Chun Ang Ali Kucukmetin et al.	Risk factors for lesser sac metastasis in advanced ovarian cancer.	2016
Dr Asima Mukhopadhyay Michelle Dixon Dr Evan Mulligan James Murray Professor Nicola Curtin et al.	Evaluation of different methods to assess homologous recombination status and sensitivity to parp inhibitors in ovarian cancer	2014
Professor Richard Edmondson Dr Asima Mukhopadhyay Professor Nicola Curtin	Molecular characterization of matched ovarian ascites and tumors suggests multiple mechanisms for a homologous recombination defective phenotype	2014
Dr Rachel O'Donnell Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon Dr Angelika Kaufmann et al.	The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis	2014
Dr Rachel O'Donnell Laura Woodhouse Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon et al.	Functional Intra-Tumour Heterogeneity in Ovarian Cancer: What is a Representative Tumour Sample?	2013